Quantum Biopharma Class B Subordinate Voting Shares
QNTM
14 hedge funds and large institutions have $445K invested in Quantum Biopharma Class B Subordinate Voting Shares in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 2 closing their positions.
771% more call options, than puts
Call options by funds: $61K | Put options by funds: $7K
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
0% less ownership
Funds ownership: 0.03% → 0.02% (-0%)
7% less funds holding
Funds holding: 15 → 14 (-1)
16% less capital invested
Capital invested by funds: $527K → $445K (-$82.5K)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$26.6K |
| 2 |
Jane Street
New York
|
+$6.2K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$3.6K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$111 |
| 5 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
+$55 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
-$71.2K |
| 2 |
Creative Planning
Overland Park,
Kansas
|
-$11K |
| 3 |
Wolverine Trading
Chicago,
Illinois
|
-$10.2K |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$609 |
| 5 |
Renaissance Technologies
New York
|
-$387 |
QNTM Hedge Fund Activity: Q4 2022 in Review
14 of the 6,223 institutional investors tracked by Wall St. Rank reported a position in Quantum Biopharma Class B Subordinate Voting Shares (QNTM) for Q4 2022, worth a combined $445K — down 16% from $527K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of QNTM and 1 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 4 added.
The largest buyer was Susquehanna International Group, adding an estimated $26.6K. The largest seller was AdvisorShares Investments, cutting an estimated $71.2K.
- 14 institutional investors held Quantum Biopharma Class B Subordinate Voting Shares (QNTM) as of Q4 2022, down from 15 in Q3 2022.
- Funds reported $445K of Quantum Biopharma Class B Subordinate Voting Shares stock for Q4 2022, down 16% quarter-over-quarter.
- 1 fund opened new Quantum Biopharma Class B Subordinate Voting Shares positions in Q4 2022 and 2 closed out, a net change of -1 holder.
- The largest Quantum Biopharma Class B Subordinate Voting Shares buyer in Q4 2022 was Susquehanna International Group, an estimated $26.6K added.
- The largest Quantum Biopharma Class B Subordinate Voting Shares seller in Q4 2022 was AdvisorShares Investments, an estimated $71.2K sold.
Based on aggregated 13F filings for Q4 2022.